
David and Goliath: How Can First-Time Launchers Avoid Failure and Beat Big Pharma Launches with Rohit Sood, Executive Vice President at EVERSANA
Pharma Launch Secrets
00:00
The Advantage of Ownership Incentives for First-Time Pharma Launchers and the Potential of Neuroscientific Treatments
Discussion on the importance of aligning incentives in first-time pharma companies and exploring therapeutic areas such as sell and gene therapy, CNS neuroscience, and oncology.
Transcript
Play full episode